mm-398 for second-line therapy in advanced pancreatic cancer
Published 8 years ago • 814 plays • Length 4:22Download video MP4
Download video MP3
Similar videos
-
4:48
liposomal irinotecan in advanced pancreatic cancer
-
3:31
second-line decision-making in pancreatic cancer
-
1:12
elucidating the optimal second-line therapy in metastatic pancreatic cancer
-
2:48
george p. kim, md: the significance of second-line therapy in pancreatic cancer
-
0:53
second-line treatment strategies for pancreatic cancer
-
2:13
pancreatic cancer: looking beyond second-line therapy
-
1:56
eileen m. o'reilly, md: the significance of second-line therapy in pancreatic cancer
-
38:24
current and future directions in metastatic pancreatic cancer
-
5:03
sequencing decisions in advanced pancreatic cancer
-
3:27
second-line pancreatic cancer: nanoliposomal irinotecan
-
1:29
dr. ocean on the development of nanoliposomal irinotecan in metastatic pancreatic cancer
-
2:39
metastatic pancreas cancer: beyond second-line treatment
-
7:02
therapy for locally advanced pancreatic cancer
-
2:33
promising clinical trials in front- & second-line therapy for advanced metastatic pancreatic cancer
-
6:44
pancreatic cancer therapeutic sequencing
-
5:39
the napoli-1 trial in pancreatic cancer
-
0:52
dr. cohn on frontline therapies in metastatic pancreatic cancer
-
0:57
dr. pant on choosing therapy for frontline and beyond in pancreatic cancer
-
12:23
emerging therapies for pancreatic cancer